Purchase Order 75D30121P10272
Award Date 2/12/21
Potential Completion Date 1/31/26
Potential Value $97K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Lancaster, CA 93534, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $375,965.05 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Simulations Plus Inc. for GastroPlus, DDDPlus, and MembraneePlus software licenses. The contract has an ultimate completion date of August 31, 2026 and does not have a set-aside designation. Simulations Plus is a for-profit company that specializes in developing pharmaceutical modeling and simulation software, including tools for physiologically-based pharmacokinetic (PBPK) modeling, drug...
- The U.S. Food and Drug Administration (FDA) awarded a firm-fixed-price purchase order to Simulations Plus Inc., a for-profit software company specializing in pharmaceutical modeling and simulation. The contract, valued at $109,798.77, is for the purchase of 50 GastroPlus licenses, 30 IVIVCPlus module licenses, and 30 PBPK Plus licenses. The contract has no set-aside designation and is not associated with a larger contract vehicle. Simulations Plus has previously provided similar software...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Simulations Plus Inc., a small business for-profit software company, for the procurement of GastroPlus software licenses. The $252,421.24 contract provides the FDA access to Simulations Plus' physiologically-based pharmacokinetic (PBPK) modeling and simulation software, which supports research and regulatory decision-making in pharmaceutical development and assessment. The award does not appear to be...
- This is a firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Simulations Plus Inc. for the renewal of ADMET Predictor software licenses and associated support services. The contract, valued at $100,337.38, has an ultimate completion date of February 19, 2026. The original solicitation sought to renew the FDA's existing licenses for the ADMET Predictor software, which is used by the Center for Tobacco Products (CTP) for toxicology data mining and assessing the...
- The Defense Health Agency awarded a $144,335 firm fixed-price purchase order to Simulations Plus Inc. on September 15, 2022, for software licensing to support analysis research efforts. The contract calls for the purchase of GastroPlus licenses, a simulation software package that models drug absorption, pharmacokinetics, and pharmacodynamics across multiple administration routes including intravenous, oral, ocular, inhalation, dermal, subcutaneous, and intramuscular pathways in animal...
- This is a $1,844,289.00 definitive cost-no-fee contract awarded by the Food and Drug Administration (FDA) to the University of Florida (UF) Division of Sponsored Research. The contract is for advancing in vitro and (patho)physiology-based pharmacokinetics models to understand and predict pulmonary absorption and tissue retention of inhaled drugs. The contract has no set-aside designation. As a subcontractor, Simulations Plus Inc. will provide modeling and simulation services to support the...
- The U.S. Food and Drug Administration (FDA) awarded a $144,000.00 firm-fixed-price purchase order contract to Certara UK LIMITED, doing business as Certara, for the purchase of SIMCYP software. SIMCYP is a physiologically-based pharmacokinetic (PBPK) modeling software used to simulate drug absorption, distribution, metabolism, and excretion processes, which is crucial for optimizing drug development and facilitating regulatory reviews. This contract is not set aside for any specific business...
- The U.S. Food and Drug Administration (FDA) awarded a firm fixed price purchase order to Certara UK Limited, doing business as Certara, a for-profit limited liability company, for SIMCYP software licenses and maintenance support. The $114,316.00 contract will allow the FDA's Office of Clinical Pharmacology Drug Reviewers to complete their review of investigational new drugs. Certara has previously provided this physiologically-based pharmacokinetic modeling software to the FDA and...
- This is a firm-fixed-price purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Mechanical Simulation Corp. for maintenance, technical support, and licensing of the company's proprietary vehicle simulation software, including TruckSim, CarSim, and SuspensionSim. The contract has a ceiling value of $125,000.00 and a period of performance ending on June 29, 2016. The software products are used by various federal agencies,...
- This is a $169,504.71 firm-fixed price purchase order awarded by the U.S. Department of Health and Human Services (HHS) Food and Drug Administration (FDA) to Certara USA Inc., doing business as Tripos (DE), a technology-enabled drug development and drug safety consultancy. The contract provides annual named user server licenses for Certara's Phoenix WinNonlin, Phoenix Connect, Phoenix NLME software, as well as an unlimited server license for distributed computing. This supports the FDA's...